Q1 2016 Holdings
Filed 2016-05-13 | 51 holdings | $20.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-05-16) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $8.5M | 450,000 | 42.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $5.7M | 140,000 | 28.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $3.3M | 40,000 | 16.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.1M | 75,000 | 10.4% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $407.0K | 50,000 | 2.0% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $11.0K | 220,000 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD)Put | COM | 004225108 | $9.8K | 350,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $9.0K | 90,202 | 0.0% |
| Edwards Lifesciences Corp(EW)Call | COM | 28176E108 | $8.8K | 100,000 | 0.0% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $8.3K | 75,000 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $7.0K | 425,000 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $6.0K | 700,000 | 0.0% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $5.7K | 100,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $5.6K | 40,000 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | ADR | 881624209 | $5.4K | 100,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.4K | 250,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.1K | 160,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $5.1K | 350,000 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $5.1K | 120,000 | 0.0% |
| Ishares TR(IHF) | US HLTHCR PR ETF | 464288828 | $4.8K | 39,500 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $4.2K | 75,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $3.4K | 225,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $3.4K | 70,000 | 0.0% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $3.4K | 50,000 | 0.0% |
| Ishares TR(IHI) | U.S. MED DVC ETF | 464288810 | $3.1K | 25,000 | 0.0% |
| Resmed Inc(RMD) | COM | 761152107 | $2.9K | 50,000 | 0.0% |
| Valeant Pharmaceuticals IntlCall | COM | 91911K102 | $2.6K | 100,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $2.6K | 45,000 | 0.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $2.1K | 125,000 | 0.0% |
| Portola Pharmaceuticals IncCall | COM | 737010108 | $2.0K | 100,000 | 0.0% |
| ST Jude MED Inc | COM | 790849103 | $2.0K | 36,500 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.0K | 25,253 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $2.0K | 110,000 | 0.0% |
| Medtronic PLC(MDT) | COM | G5960L103 | $2.0K | 26,578 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $1.9K | 250,000 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $1.8K | 341,708 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $1.8K | 151,535 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $1.6K | 300,000 | 0.0% |
| Ishares TR(IHE) | U.S. PHARMA ETF | 464288836 | $1.3K | 9,800 | 0.0% |
| Tandem Diabetes Care Inc | COM | 875372104 | $1.3K | 150,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $1.3K | 250,000 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $1.1K | 300,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $816 | 40,000 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $687 | 75,000 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $678 | 24,100 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $671 | 101,188 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $653 | 46,622 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $475 | 25,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $355 | 18,500 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $332 | 72,726 | 0.0% |